Start Free Trial
Pricing
Log In
Log In
Upgrade browser for full Crunchbase experience. You're accessing Crunchbase in a browser that is no longer supported.
Learn More
Syntaxis Logo
Syntaxis Growth Score
32
CB Rank
223683
Heat Score
64
Syntaxis is committed to discovering, developing and commercialising novel therapeutics that enhance recovery of brain functions.
Founded
obfuscation
PrivateSeed Lund, Skane Lan, Sweden1-10 www.sinntaxis.com/
Biotechnology
Health Care
Therapeutics
Overview

Syntaxis
Total Funding
obfuscation
Growth Score
32
Heat Score
64

Total Funding
obfuscation
Seed raised
obfuscation
Growth Score32
-1 pts
in past quarter
Heat Score 64
-13 pts
in past quarter

Company Performance Metrics

Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Learn More >
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience

About Syntaxis

CB Rank
223683
Syntaxis is committed to discovering, developing and commercialising novel therapeutics that enhance recovery of brain functions.
Founded
obfuscation
PrivateSeed Lund, Skane Lan, Sweden1-10 www.sinntaxis.com/
Biotechnology
Health Care
Therapeutics

Funding Rounds

Seed
OBF
in
obfuscation
Grant
OBF
in
obfuscation

Key People

Details

Legal Name Sinntaxis AB
Operating Status Active
Company Type For Profit
Founders  Carin Sjölund, Karsten Ruscher, Kerstin Beirup, Roger Olsson, Tadeusz Wieloch
About the Company
Syntaxis is committed to discovering, developing and commercialising novel therapeutics that enhance recovery of brain functions after stroke.
Phone Number 46 7 07 18 89 30
Contact Email sinntaxis@gmail.com
Predictions & Insights

Growth Prediction

See this Growth Prediction

Unlock More with Crunchbase Pro
  • Full access to financial & funding data on unlimited profiles
  • Export up to 2k results/month for analysis
  • Track market signals on competitors, products, and R&D
  • Preview private company insights and predictions
Financials

Company Funding

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - Syntaxis Logo
Seed Round - Syntaxis
1
obfuscation
— Seed
obfuscation
Seed Round - Syntaxis Logo
Seed Round - Syntaxis
1
obfuscation
— Seed
obfuscation
Seed Round - Syntaxis Logo
Seed Round - Syntaxis
1
obfuscation
— Seed
obfuscation
Seed Round - Syntaxis Logo
Seed Round - Syntaxis
1
obfuscation
— Seed
obfuscation
Seed Round - Syntaxis Logo
Seed Round - Syntaxis
1
obfuscation
— Seed

Funding Rounds

Total Funding Amount 
obfuscation
Number of Funding Rounds 2
Unlock company funding data, including rounds, dates, amounts, and investors.
Announced Date  
Transaction Name  
Number of Investors  
Money Raised  
Lead Investors  
Funding Type  
obfuscation
Seed Round - Syntaxis Logo
Seed Round - Syntaxis
1
obfuscation
— Seed
obfuscation
Seed Round - Syntaxis Logo
Seed Round - Syntaxis
1
obfuscation
— Seed
obfuscation
Seed Round - Syntaxis Logo
Seed Round - Syntaxis
1
obfuscation
— Seed
obfuscation
Seed Round - Syntaxis Logo
Seed Round - Syntaxis
1
obfuscation
— Seed
obfuscation
Seed Round - Syntaxis Logo
Seed Round - Syntaxis
1
obfuscation
— Seed

Investors

Unlock company funding data, including rounds, dates, amounts, and investors.
Investor Name  
Lead Investor  
Funding Round  
Partners  
LU Innovation Logo
LU Innovation
—
Seed Round - Syntaxis Logo
Seed Round - Syntaxis
—
LU Innovation Logo
LU Innovation
—
Seed Round - Syntaxis Logo
Seed Round - Syntaxis
—
LU Innovation Logo
LU Innovation
—
Seed Round - Syntaxis Logo
Seed Round - Syntaxis
—
LU Innovation Logo
LU Innovation
—
Seed Round - Syntaxis Logo
Seed Round - Syntaxis
—
LU Innovation Logo
LU Innovation
—
Seed Round - Syntaxis Logo
Seed Round - Syntaxis
—
Market Intelligence
People
View Profiles & Contacts
Headcount 1-10 Employee Profiles 2 Board Members and Advisors 2

Employee Profiles

Board Members and Advisors

News

News and Press

News•Apr 30, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
News•Apr 29, 2025
obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated obfuscated
Access a complete feed of recent news and press, from product launches to leadership changes.
Technology
View Tech Report

Monthly Web Visits

155
171.93%
 in past month

IT Spend

$63.4KThis year, Syntaxis is projected to spend $63.4K on IT, according to Aberdeen.

Active Website Tech Count

2Syntaxis is actively using 2 technologies for its website, according to BuiltWith. These include CommonCrawl Top 5m.

Total IP

3The intellectual property of Syntaxis includes 3 registered patents primarily in the 'Medical Or Veterinary Science; Hygiene' category, according to IPqwery.
Sub-Organizations
Frequently Asked Questions

Where is Syntaxis's headquarters? Syntaxis is located in Lund, Skane Lan, Sweden.Who invested in Syntaxis? Syntaxis has 3 investors including LU Innovation and  SmiLe Incubator.When was the last funding round for Syntaxis? Syntaxis closed its last funding round on
obfuscation
from a Seed round.Who are Syntaxis's competitors? Alternatives and possible competitors to Syntaxis may include AbbVie, Roche, and  Cognition Therapeutics.How much funding has Syntaxis raised to date? Syntaxis has raised
obfuscation
.
Who We Are
What We Do
Helpful Links
AI Content may contain mistakes and is not legal, financial or investment advice. Learn more.
Terms of Service | Privacy Policy | Sitemap | © 2026 Crunchbase Inc. All Rights Reserved.
(05b78c5 1)
|